Pathstone Family Office’s Vanguard Health Care ETF VHT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$2.51M Buy
10,658
+36
+0.3% +$8.78K 0.02% 425
2023
Q2
$2.6M Buy
10,622
+201
+2% +$48.9K 0.04% 271
2023
Q1
$2.49M Buy
10,421
+3,529
+51% +$849K 0.04% 253
2022
Q4
$53.5M Buy
6,892
+4,994
+263% +$1.21M 0.46% 47
2022
Q3
$425K Buy
+1,898
New +$453K ﹤0.01% 1135
2022
Q2
Sell
-1,160
Closed -$295K 1148
2022
Q1
$295K Buy
+1,160
New +$287K 0.01% 757
2021
Q1
Sell
-76
Closed -$17K 1320
2020
Q4
$17K Sell
76
-1,202
-94% -$257K ﹤0.01% 748
2020
Q3
$261K Buy
+1,278
New +$259K 0.03% 169
2020
Q2
Sell
-76
Closed -$13K 978
2020
Q1
$13K Buy
+76
New +$13.9K ﹤0.01% 491

Other funds holding VHT

Pathstone Family Office's VHT Position: Q3 2023 in Review

Pathstone Family Office increased its Vanguard Health Care ETF (VHT) stake by 0.34% in Q3 2023, buying an estimated $8.78K and bringing the position to 10,658 shares worth $2.51M. The position accounts for 0.02% of the portfolio, ranked #425.

Pathstone Family Office first reported a position in VHT in Q1 2020 and has held it in 9 quarters since. The position peaked at $53.5M in Q4 2022. 928 funds tracked by Wall St. Rank hold VHT as of Q3 2023.

  • Pathstone Family Office held 10,658 shares of Vanguard Health Care ETF worth $2.51M as of Q3 2023.
  • Pathstone Family Office bought 36 Vanguard Health Care ETF shares in Q3 2023, an estimated $8.78K.
  • Vanguard Health Care ETF made up 0.02% of Pathstone Family Office's portfolio in Q3 2023, its #425 holding.
  • Pathstone Family Office first reported a position in Vanguard Health Care ETF in Q1 2020 and has held it in 9 quarters since.
  • Pathstone Family Office's Vanguard Health Care ETF position peaked at $53.5M in Q4 2022.
  • 928 funds tracked by Wall St. Rank held Vanguard Health Care ETF as of Q3 2023.

Based on Pathstone Family Office's 13F filing for Q3 2023, filed 8 Nov 2023.